Authors:
Osman, I
Scher, HI
Drobnjak, M
Verbel, D
Morris, M
Agus, D
Ross, JS
Cordon-Cardo, C
Citation: I. Osman et al., HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer, CLIN CANC R, 7(9), 2001, pp. 2643-2647
Authors:
Polsky, D
Bastian, BC
Hazan, C
Melzer, K
Pack, J
Houghton, A
Busam, K
Cordon-Cardo, C
Osman, I
Citation: D. Polsky et al., HDM2 protein overexpression, but not gene amplification, is related to tumorigenesis of cutaneous melanoma, CANCER RES, 61(20), 2001, pp. 7642-7646
Authors:
Drobnjak, M
Osman, I
Scher, HI
Fazzari, M
Cordon-Cardo, C
Citation: M. Drobnjak et al., Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone, CLIN CANC R, 6(5), 2000, pp. 1891-1895
Authors:
Kelly, WK
Osman, I
Reuter, VE
Curley, T
Heston, WDW
Nanus, DM
Scher, HI
Citation: Wk. Kelly et al., The development of biologic end points in patients treated with differentiation agents: An experience of retinoids in prostate cancer, CLIN CANC R, 6(3), 2000, pp. 838-846
Authors:
Lee, CT
Capodieci, P
Osman, I
Fazzari, M
Ferrara, J
Scher, HI
Cordon-Cardo, C
Citation: Ct. Lee et al., Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer, CLIN CANC R, 5(5), 1999, pp. 977-983
Authors:
Orlow, I
LaRue, H
Osman, I
Lacombe, L
Moore, L
Rabbani, F
Meyer, F
Fradet, Y
Cordon-Cardo, C
Citation: I. Orlow et al., Deletions of the INK4A gene in superficial bladder tumors - Association with recurrence, AM J PATH, 155(1), 1999, pp. 105-113